プロトンポンプ
- 阻害剤の選択性比較
- 溶解度
カタログ番号 | 製品カタログ | 溶解度(25°C) | ||
---|---|---|---|---|
水 | DMSO | アルコール | ||
S1354 | Lansoprazole | <1 mg/mL | 74 mg/mL | 14 mg/mL |
S1389 | Omeprazole | <1 mg/mL | 69 mg/mL | 13 mg/mL |
S1413 | Bafilomycin A1(Baf-A1) | <1 mg/mL | 6 mg/mL | <1 mg/mL |
S1743 | NEXIUM (esomeprazole magnesium) | <1 mg/mL | 143 mg/mL | 143 mg/mL |
S4075 | Zinc Pyrithione | <1 mg/mL | 30 mg/mL | <1 mg/mL |
S3666 | Ilaprazole | <1 mg/mL | 73 mg/mL | 14 mg/mL |
S2222 | PF-3716556 | <1 mg/mL | 79 mg/mL | 79 mg/mL |
S4099 | Dexlansoprazole | <1 mg/mL | 74 mg/mL | <1 mg/mL |
S4212 | Tenatoprazole | <1 mg/mL | 46 mg/mL | 14 mg/mL |
S4665 | Rebeprazole sodium | 76 mg/mL | 76 mg/mL | 76 mg/mL |
S4538 | Pantoprazole sodium | 81 mg/mL | 81 mg/mL | 81 mg/mL |
S2105 | Pantoprazole | <1 mg/mL | 76 mg/mL | 76 mg/mL |
- Proton Pump阻害剤(12)
- 新Proton Pump製品
製品コード | 製品説明 | 文献中の使用例 | お客様のフィードバック |
---|---|---|---|
S1354 |
LansoprazoleLansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid. |
||
S1389 |
OmeprazoleOmeprazole is a proton pump inhibitor, used to treat dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome. |
||
S1413 |
Bafilomycin A1(Baf-A1)Bafilomycin A1 is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM. |
![]() ![]() Expressions of LC3-I and LC3-II in protein were detected by Western blotting. Bafilomycin A1 significantly inhibited the effect of PNU282987 on LC3-II/I ratio in LPS-stimulated BV2 microglia (n = 6 per group).
|
|
S1743 |
NEXIUM (esomeprazole magnesium)Esomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion. |
||
S4075 |
Zinc PyrithioneZinc pyrithione is an antifungal and antibacterial agent disrupting membrane transport by blocking the proton pump. |
||
S3666新 |
IlaprazoleIlaprazole is a new proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer. It inhibits H+/K+-ATPase with an IC50 of 6.0 μM. |
||
S2222 |
PF-3716556PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively, inhibits gastric acid secretion, displays no activity at Na+,K+-ATPase, used for the treatment of gastroesophageal reflux disease. |
||
S4099 |
DexlansoprazoleDexlansoprazole, the dextrorotatory enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties. |
||
S4212 |
TenatoprazoleTenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM. |
||
S4665 |
Rebeprazole sodiumRabeprazole is an antiulcer drug in the class of proton pump inhibitors. |
||
S4538 |
Pantoprazole sodiumPantoprazole is a proton pump inhibitor drug that inhibits gastric acid secretion. It works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid. |
||
S2105 |
PantoprazolePantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. |